|
|
Blood, 15 February 2007, Vol. 109, No. 4, pp. 1611-1619.
Prepublished online as a Blood First Edition Paper on October 10, 2006; DOI 10.1182/blood-2006-03-008441.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
CpG DNA activation and plasma-cell differentiation of CD27 naive human B cells
Jennifer Huggins1,
Tina Pellegrin2,
Raymond E. Felgar3,
Chungwen Wei1,
Miguel Brown2,
Bo Zheng1,
Eric C. B. Milner1,
Steven H. Bernstein4,
Ignacio Sanz1, and
Martin S. Zand2
1 Division of Allergy, Immunology and Rheumatology,
2 Division of Nephrology,
3 Department of Pathology,
4 James P. Wilmot Cancer Center, University of Rochester Medical Center, NY
Unmethylated CpG DNA activation of naive CD27 B cells has been reported to require B-cellreceptor (BCR) cross-linking. We describe a culture system using CpG DNA with sequential steps for T-cellindependent activation of naive CD19+CD27 human peripheral blood B cells that induces efficient CD138+ plasma-cell differentiation. CD27+ and CD27 B cells were cultured in a 3-step system: (1) days 0 to 4: CpG, IL-2/10/15; (2) days 4 to 7: IL-2/6/10/15 and anti-CD40L; (3) days 7 to 10: IL-6/15, IFN- , hepatocyte growth factor, and hyaluronic acid. Both CD27+ and CD27 B cells up-regulated intracytoplasmic TLR-9 following CpG DNA activation. CD27 B-cell activation required cell-cell contact. Both naive and memory B cells progressed to a plasma-cell phenotype: CD19lowCD20lowCD27+CD38+HLA-DRlow. Seventy percent of the CD27-derived CD138+ cells demonstrated productive V chain rearrangements without somatic mutations, confirming their origin from naive precursors. Plasma cells derived from CD27+ B cells were primarily IgG+, while those from CD27 B cells were IgM+. Our results indicate that under certain conditions, naive B cells increase TLR-9 expression and proliferate to CpG DNA stimulation without BCR signaling. In addition to its immunologic significance, this system should be a valuable method to interrogate the antigenic specificity of naive B cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Malaspina, S. Moir, A. C. DiPoto, J. Ho, W. Wang, G. Roby, M. A. O'Shea, and A. S. Fauci
CpG Oligonucleotides Enhance Proliferative and Effector Responses of B Cells in HIV-Infected Individuals
J. Immunol.,
July 15, 2008;
181(2):
1199 - 1206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Capolunghi, S. Cascioli, E. Giorda, M. M. Rosado, A. Plebani, C. Auriti, G. Seganti, R. Zuntini, S. Ferrari, M. Cagliuso, et al.
CpG Drives Human Transitional B Cells to Terminal Differentiation and Production of Natural Antibodies
J. Immunol.,
January 15, 2008;
180(2):
800 - 808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N.-H. Chang, T. McKenzie, G. Bonventi, C. Landolt-Marticorena, P. R. Fortin, D. Gladman, M. Urowitz, and J. E. Wither
Expanded Population of Activated Antigen-Engaged Cells within the Naive B Cell Compartment of Patients with Systemic Lupus Erythematosus
J. Immunol.,
January 15, 2008;
180(2):
1276 - 1284.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |